Shrimp miR-S8 Suppresses the Stemness of Human Melanoma Stem-like Cells by Targeting the Transcription Factor YB-1
Authors:
Open Access
- 15 October 2017
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 77 (20) , 5543-5553
Abstract
Cross-species regulation of gene expression by microRNA is a possible untapped opportunity for miRNA-based therapy. In this study, we report a novel approach to ablate melanoma stem-like cells by targeting the transcription factor YB-1, which is significantly and selectively upregulated in these cells in melanoma. Silencing YB-1 expression was sufficient to significantly inhibit the stemness of melanoma stem-like cells. In exploring YB-1 targeting, we discovered that the shrimp microRNA miR-S8 could suppress human YB-1 expression in melanoma stem-like cells. Mechanistic investigations revealed that miR-S8 recognized the 3′UTR of YB-1 mRNA and mediated its degradation. In tumor cell and xenograft experiments, miR-S8 suppressed the tumorigenic capacity of melanoma stem-like cells by targeting human YB-1. Overall, our results illuminated a novel aspect of miRNA-mediated cross-species gene expression and its use in regulating cancer stem-like cells. Cancer Res; 77(20); 5543–53. ©2017 AACR.Keywords
Funding Information
- National Natural Science Foundation of China (31430089)
- National Program on the Key Basic Research* (2015CB755903)
This publication has 40 references indexed in Scilit:
- Y-box-binding protein 1 (YB-1) and its functionsBiochemistry (Moscow), 2011
- Pluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved IssuesCell, 2010
- Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem CellsCell, 2009
- Origins and Mechanisms of miRNAs and siRNAsCell, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Deadenylation is a widespread effect of miRNA regulationRNA, 2008
- CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosisBritish Journal of Cancer, 2008
- Let Me Count the Ways: Mechanisms of Gene Regulation by miRNAs and siRNAsMolecular Cell, 2008
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005